Significant Ownership of Sio Capital Management, LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Sio Capital Management, LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Jin W. Lee - Chief Compliance Officer
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Sio Capital Management, LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Sio Capital Management, LLC
Significant Ownership of Sio Capital Management, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SER | SERINA THERAPEUTICS, INC. | Common Stock, par value, $0.0001 per share | 6.7% | $1,970,000 | 1,000,000 | Sio Capital Management, LLC | 31 Mar 2026 | ||
| Anteris Technologies Global Corp. | Common Stock, par value $0.0001 per share | 5.5% | 5,382,965 | Sio Capital Management, LLC | 31 Mar 2026 | ||||
| ALGS | Aligos Therapeutics, Inc. | Common Stock, par value, $0.0001 per share | 5.5% | $3,104,058 | -$184,800 | 335,937 | -5.6% | Sio Capital Management, LLC | 31 Dec 2025 |
| APRE | Aprea Therapeutics, Inc. | Common stock, par value $0.001 per share | 5.1% | $138,302 | 276,603 | Sio Capital Management, LLC | 31 Dec 2024 | ||
| PMVP | PMV Pharmaceuticals, Inc. | Common stock, par value $0.00001 per share | 4.9% | $3,398,037 | -$570,751 | 2,634,137 | -14% | Sio Capital Management, LLC | 30 Jun 2026 |
| AVR | Anteris Technologies Global Corp. | Common Stock, par value $0.0001 per share | 4.9% | $7,976,704 | -$5,226,417 | 1,772,601 | -40% | Sio Capital Management, LLC | 30 Sep 2025 |
| NMTC | NeuroOne Medical Technologies Corp | Common Stock, par value, $0.001 per share | 4.7% | $2,098,132 | -$1,033,699 | 2,360,635 | -33% | Sio Capital Management, LLC | 30 Sep 2025 |
| VTYX | Ventyx Biosciences, Inc. | Common Stock, $0.0001 par value per share | 3.6% | $3,254,145 | -$1,844,819 | 2,582,655 | -36% | Sio Capital Management, LLC | 31 Mar 2025 |
| ADGM | Adagio Medical Holdings, Inc. | Common Stock, par value, $0.0001 per share | 3.2% | $455,741 | -$384,336 | 698,989 | -46% | Sio Capital Management, LLC | 30 Jun 2026 |
| DRUG | Bright Minds Biosciences Inc. | Common Shares | 2.7% | $11,571,744 | -$19,506,679 | 190,764 | -63% | Sio Capital Management, LLC | 30 Sep 2025 |
| VXRT | Vaxart, Inc. | Common Stock, $0.0001 par value per share | 2.4% | $2,400,883 | -$2,550,703 | 5,583,448 | -52% | Sio Capital Management, LLC | 31 Mar 2025 |
| APRE | Aprea Therapeutics, Inc. | Common stock, par value $0.001 per share | 1.9% | $165,529 | -$246,540 | 112,223 | -60% | Sio Capital Management, LLC | 30 Sep 2025 |
| MODD | Modular Medical, Inc. | Common stock, par value $0.001 per share | 0.73% | $219,231 | 251,990 | Sio Capital Management, LLC | 31 Dec 2024 | ||
| QTTB | Q32 Bio Inc. | Common stock, par value $0.0001 per share | 0% | $0 | -$1,087,964 | 0 | -100% | Sio Capital Management, LLC | 31 Mar 2025 |
Schedules 13D/G Reported by Sio Capital Management, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.